Market closed
AtriCure/$ATRC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About AtriCure
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Ticker
$ATRC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,200
Website
AtriCure Metrics
BasicAdvanced
$1.5B
Market cap
-
P/E ratio
-$0.83
EPS
1.44
Beta
-
Dividend rate
Price and volume
Market cap
$1.5B
Beta
1.44
52-week high
$39.05
52-week low
$18.94
Average daily volume
420K
Financial strength
Current ratio
3.618
Quick ratio
2.489
Long term debt to equity
16.002
Total debt to equity
16.586
Interest coverage (TTM)
-5.06%
Management effectiveness
Return on assets (TTM)
-3.97%
Return on equity (TTM)
-8.39%
Valuation
Price to revenue (TTM)
3.212
Price to book
3.22
Price to tangible book (TTM)
8.71
Price to free cash flow (TTM)
-1,245.793
Growth
Revenue change (TTM)
17.56%
Earnings per share change (TTM)
54.18%
3-year revenue growth (CAGR)
20.03%
3-year earnings per share growth (CAGR)
-5.72%
What the Analysts think about AtriCure
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AtriCure stock.
AtriCure Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AtriCure Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AtriCure News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for AtriCure stock?
AtriCure (ATRC) has a market cap of $1.5B as of December 22, 2024.
What is the P/E ratio for AtriCure stock?
The price to earnings (P/E) ratio for AtriCure (ATRC) stock is 0 as of December 22, 2024.
Does AtriCure stock pay dividends?
No, AtriCure (ATRC) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next AtriCure dividend payment date?
AtriCure (ATRC) stock does not pay dividends to its shareholders.
What is the beta indicator for AtriCure?
AtriCure (ATRC) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.